Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to -$44.2 million.

  • BIO-TECHNE's Cash from Financing Activities fell 282.02% to -$44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.5 million, marking a year-over-year decrease of 39.45%. This contributed to the annual value of -$253.9 million for FY2025, which is 107.44% down from last year.
  • Per BIO-TECHNE's latest filing, its Cash from Financing Activities stood at -$44.2 million for Q3 2025, which was up 51.13% from -$90.5 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Cash from Financing Activities peaked at $150.8 million during Q1 2023, and registered a low of -$90.5 million during Q2 2025.
  • Its 3-year average for Cash from Financing Activities is -$26.7 million, with a median of -$52.4 million in 2024.
  • As far as peak fluctuations go, BIO-TECHNE's Cash from Financing Activities skyrocketed by 363.17% in 2021, and later slumped by 282.02% in 2025.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Cash from Financing Activities stood at -$53.4 million in 2021, then slumped by 35.26% to -$72.2 million in 2022, then fell by 12.75% to -$81.4 million in 2023, then dropped by 3.00% to -$83.8 million in 2024, then plummeted by 282.02% to -$44.2 million in 2025.
  • Its last three reported values are -$44.2 million in Q3 2025, -$90.5 million for Q2 2025, and -$68.0 million during Q1 2025.